FDA commissioner Robert Califf expresses concern about fake and compounded weight-loss drugs and the disparity in the availability of branded weight-l...
FDA clears a Nevro 510(k) for its Nevro1 sacroiliac joint fusion device for treating chronic SI joint pain.
Medtronic Neurology recalls its Duet External Drainage and Monitoring System, which is used to drain cerebrospinal fluid (CSF) to reduce intracranial ...
An HHS-funded RAND study finds that many new drugs are available in the U.S. before launching in other countries.
Federal Register notice: FDA issues an order to reduce a five-year debarment against former Indivior global medical director Timothy Baxter.
A detailed FDLI analysis looks at how expected Supreme Court changes to the Chevron federal agency deference principle will likely affect FDA and regu...
FDA accepts for priority review an Applied Therapeutics NDA for AT-007 (govorestat) for treating classic Galactosemia.
CBER director Peter Marks says he expects 2024 to be a big year for gene therapy approvals as several Center initiatives take hold to advance product ...
